Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study (Q34601527)
Jump to navigation
Jump to search
scientific article published on 9 December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study |
scientific article published on 9 December 2008 |
Statements
1 reference
Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study (English)
1 reference
E C Keystone
1 reference
M C Genovese
1 reference
E C Hsia
1 reference
S T Hall
1 reference
P C Miranda
1 reference
J Pazdur
1 reference
S-C Bae
1 reference
W Palmer
1 reference
J Zrubek
1 reference
M Wiekowski
1 reference
S Visvanathan
1 reference
Z Wu
1 reference
M U Rahman
1 reference
GO-FORWARD Study
1 reference
9 December 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference